JW
James B Wyngaarden
Director

James B Wyngaarden insider trades: Idera Pharmaceuticals (IDRA) stock buys and sales

Director, Idera Pharmaceuticals Last trade Jun 12, 2008 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
4
Companies
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 12, 2008IDRA↓ Sell$19K
May 16, 2008IDRA↓ Sell$89K
Mar 14, 2008IDRA↓ Sell$201K
Jan 2, 2008IDRA↑ Buy$5K
Oct 1, 2007IDP↑ Buy$2K
Jul 2, 2007IDP↑ Buy$4K
Jan 3, 2007IDP↑ Buy$6K
Oct 10, 2006IDP↑ Buy$2K
Jul 7, 2006IDP↑ Buy$3K
Apr 5, 2006IDP↑ Buy$3K
Oct 3, 2005IDP↑ Buy$3K
Jul 1, 2005HBY↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James B Wyngaarden's insider trades

James B Wyngaarden is a director at Idera Pharmaceuticals (IDRA). Since Jul 1, 2005, James has reported 9 open-market purchases worth $33K and 3 sales worth $308K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (19 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.